|
The content on or accessible through Medpedia.com is for informational purposes only. Medpedia is not a substitute for professional advice or expert medical services from a qualified health professional.
Read more
|
Rosiglitazone
There are currently no Lead Editors of this article.
Ask a Question on This Topic
Important Resources for Rosiglitazone:
The information on this page is seed content provided by an organization. Please help improve this Article by adding to it. If you are a physician or PhD, learn how to edit. If you are anyone else, learn how to suggest changes.
This is a "stub" page. Help expand Medpedia's knowledgebase by Editing or Suggesting Changes to make it more complete.
Rosiglitazone (roh-sig-LIH-tuh-zone)
The generic name for a drug that is used as an active ingredient that helps control the amount of glucose (sugar) in the blood. Because of concerns that benefit may not be out weighed by harm, regulatory authorities may have restrictions on use and in some jurisdictions its former marketing authorization has been suspended. Possible adverse effects include fluid retention, bone fractures and indeed cardiovascular disease which treatment of diabetes by lowering the glucose might be expected to prevent. It was being studied in the prevention and treatment of some types of cancer. Rosiglitazone stops cells from growing and may prevent the growth of new blood vessels that tumors need to grow. It is a type of thiazolidinedione and a type of antiangiogenesis agent.
To suggest changes to this page, you must create an account on Medpedia.